Quest Finds its Path to AI in Cancer Diagnostics Through M&A
The deal follows Labcorp, Quest’s rival, becoming the winning bidder to acquire Invitae’s assets.
The deal follows Labcorp, Quest’s rival, becoming the winning bidder to acquire Invitae’s assets.